文献速递血液净化与透析肾血管病与高血压

循环祖细胞缺乏与血液透析患者血管血栓形成相关

Deficiency of circulating progenitor cells associated with vascular thrombosis of hemodialysis patients.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

该研究纳入269例血液透析患者,2010年1月至2012年12月检测CD34+KDR+内皮祖细胞水平,前瞻性随访至2015年5月。结果显示CD34+KDR+细胞三分位越低,总体血栓事件、全身血管血栓事件和透析通路血栓事件发生率越高;多因素分析提示低CD34+KDR+细胞计数是两类血栓的独立危险因素。

要点

  • CD34+KDR+内皮祖细胞低三分位组总体血栓事件发生率61%,高三分位组40%(P=0.02)。
  • 全身血管血栓事件低三分位组27%、高三分位组10%(P=0.03);透析通路血栓事件低三分位组52%、高三分位组36%(P=0.02)。
  • 多因素分析显示低CD34+KDR+细胞计数是全身血管血栓和透析通路血栓的独立危险因素。

核心结论

  • 在血液透析患者人群中,低水平循环内皮祖细胞与血栓形成相关。

研究设计与样本

  • 研究纳入269例血液透析患者,2010年1月至2012年12月检测CD34+KDR+循环内皮祖细胞水平,每6个月前瞻性随访至2015年5月。
  • 主要结局为透析通路血栓和全身血管血栓的复合终点。

主要发现

  • 共发生141例血栓事件,其中全身血管血栓事件50例、透析通路血栓事件116例。
  • CD34+KDR+三分位与总体血栓事件呈显著负相关:低三分位61%、中三分位56%、高三分位40%(P=0.02)。
  • CD34+KDR+三分位与全身血管血栓事件呈显著负相关:低三分位27%、中三分位18%、高三分位10%(P=0.03)。
  • CD34+KDR+三分位与透析通路血栓事件呈显著负相关:低三分位52%、中三分位46%、高三分位36%(P=0.02)。
  • 单因素分析显示全身血管血栓事件与年龄、糖尿病、血脂异常、血管疾病史、尿素清除率、白蛋白和C反应蛋白(CRP)正相关,与CD34+KDR+细胞计数负相关;透析通路血栓与血管疾病史和CRP正相关,与CD34+KDR+细胞计数负相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hemodialysis (HD) patients have an increased risk of thrombosis. Endothelial progenitor cells (EPCs), which function in vascular repair, are deficient in HD patients. Nonetheless, the relationship between EPC deficiency and thrombosis in HD patients is unknown. METHODS: From January 2010 to December 2012, circulating levels of EPCs that were positive for CD34 and kinase insert domain receptor (KDR) were measured in 269 HD patients. Patients received prospective follow-ups at 6-month intervals until May 2015. The primary outcome was the composite of HD access thrombosis and systemic vascular thrombosis. RESULTS: There were 141 thrombotic events, 50 systemic vascular thrombotic events and 116 HD access thrombotic events. We found significantly negative associations between CD34 + KDR + tertile and overall thrombotic events (low: 61%; middle: 56%; high: 40%; P = 0.02), systemic vascular thrombotic events (low: 27%; middle: 18%; high: 10%; P = 0.03) and HD access thrombotic events (low: 52%; middle: 46%; high: 36%; P = 0.02). Univariate analysis indicated that systemic vascular thrombotic events were positively associated with age, diabetes, dyslipidemia, vascular disease history, urea clearance, albumin and C-reactive protein (CRP), and negatively associated with CD34 + KDR + cell count. HD access thrombosis was positively associated with vascular disease history and CRP, and negatively associated with CD34 + KDR + cell count. Multivariate analysis indicated that a low CD34 + KDR + cell count was an independent risk factor for both types of thrombosis. CONCLUSIONS: Our study of a population of HD patients showed that a low level of circulating EPCs is associated with thrombosis.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Hsieh MY, Chen TY, Lin L, et al. Deficiency of circulating progenitor cells associated with vascular thrombosis of hemodialysis patients. Nephrol Dial Transplant. 2017. PMID: 28339557. doi:10.1093/ndt/gfw401

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。